HIGHLIGHTS
- who: Daichi Nagashima and colleagues from the General Health Medical Research Center, Yokohama University of Pharmacy, Yokohama, Japan have published the research: Human Recombinant Lactoferrin Promotes Differentiation and Calcification on MC3T3-E1 Cells, in the Journal: Pharmaceutics 2023, 15, 60. of /2023/
- what: This study aimed to characterize the molecular mechanisms of bovine (IF-I) and human (LF-II) MC3T3-E1 pre-osteoblast cells. The hypothesis which human recombinant LF would promote calcification on MT3T3E1 cells was accepted because of following results; this study demonstrated that LF treatment for 1 and 4 weeks promoted calcification . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.